Financial Gravity Companies’s Galectin Therapeutics GALT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$12.7K	Buy	+5,997	New	+$12.7K	﹤0.01%	538
2024 Q4	$7.74K	Buy	+5,997	New	+$7.74K	﹤0.01%	619